Similar articles

• Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells.

  Han S, Kim K, Song Y, Kim H, Kwon J, Lee YH, Lee CK, Lee SJ, Ha N, Kim K. Han S, et al. Arch Pharm Res. 2008 Mar;31(3):370-6. doi: 10.1007/s12272-001-1166-9. Epub 2008 Apr 13. Arch Pharm Res. 2008. PMID: 18409052
• Peptide interactions with class I and II MHC encoded molecules.

  Pecht I. Pecht I. Isr J Med Sci. 1994 Mar;30(3):28-31. Isr J Med Sci. 1994. PMID: 7514162 No abstract available.
• [Viral strategies of interference with MHC functions].

  Ishido S, Goto E, Sato Y, Hotta H. Ishido S, et al. Tanpakushitsu Kakusan Koso. 2002 Dec;47(16 Suppl):2145-51. Tanpakushitsu Kakusan Koso. 2002. PMID: 12518428 Review. Japanese. No abstract available.
• Dendritic cells: open for presentation business.

  Saveanu L, van Endert P. Saveanu L, et al. Nat Immunol. 2005 Jan;6(1):7-8. doi: 10.1038/ni0105-7. Nat Immunol. 2005. PMID: 15611772 No abstract available.
• Pathways of antigen processing.

  Blum JS, Wearsch PA, Cresswell P. Blum JS, et al. Annu Rev Immunol. 2013;31:443-73. doi: 10.1146/annurev-immunol-032712-095910. Epub 2013 Jan 3. Annu Rev Immunol. 2013. PMID: 23298205 Free PMC article. Review.